(Q86309140)

English

Earlier sustained virologic response end points for regulatory approval and dose selection of hepatitis C therapies

scientific article published on 05 March 2013

Statements

Earlier sustained virologic response end points for regulatory approval and dose selection of hepatitis C therapies (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit